Loading stock data…
Loading stock data…
US$59.22
Get one email when MBX crosses your level. Checked every 15 minutes during market hours.
▼ -1.46 (-2.40%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
66.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
6.03
Bearish momentumMACD below its signal line (6.31).
50-day average
41.84
Price aboveShort-term trend reference.
200-day average
32.44
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Mbx Biosciences Inc. is a biopharmaceutical company focused on the research and development of innovative endocrine therapeutics. It strives to address unmet medical needs through pioneering treatments for endocrine disorders. The company's central aim is to develop precision endocrinology therapies, leveraging proprietary technologies to create treatment options that are more precise and effective for specific patient populations. Mbx Biosciences operates at the intersection of biotechnology an…
mbxbio.com5 strong buy · 9 buy · 1 hold · 1 sell · 0 strong sell (16 analysts, 2026-07-01)
5 strong buy · 9 buy · 1 hold · 1 sell · 0 strong sell (16 analysts, 2026-06-01)
5 strong buy · 8 buy · 1 hold · 1 sell · 0 strong sell (15 analysts, 2026-05-01)
5 strong buy · 8 buy · 1 hold · 1 sell · 0 strong sell (15 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-07 | -0.58 | -0.51 | ✓ Beat |
| 2026-04-23 | 0.93 | 0.96 | ✓ Beat |
| 2026-03-12 | -0.6 | -0.49 | ✓ Beat |
| 2025-11-06 | -0.68 | -0.63 | ✓ Beat |
| 2025-10-13 | 0.02 | 0.03 | ✓ Beat |
| 2025-08-07 | -0.76 | -0.58 | ✓ Beat |
| 2025-05-12 | -0.77 | -0.71 | ✓ Beat |
| 2025-03-17 | -0.59 | -0.47 | ✓ Beat |
Companies in the same industry, via Finnhub